Cargando…
Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated
Purpose To investigate an endophthalmitis outbreak in different eye hospitals after intravitreal (IVT) bevacizumab (Avastin) injections over two days. Place and duration of the study Mughal Eye Hospital, Nov 2022 to Jan 2023. Materials and methods All cases reported with endophthalmitis in Mughal Ey...
Autores principales: | Shoaib, Khawaja K, Abid, Muhammad Awaid, Aziz, Saad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145693/ https://www.ncbi.nlm.nih.gov/pubmed/37123683 http://dx.doi.org/10.7759/cureus.36769 |
Ejemplares similares
-
Incidence of Acute Endophthalmitis After Intravitreal Bevacizumab Injection at a Tertiary Care Hospital in Lahore
por: Ahmed, Nasir, et al.
Publicado: (2021) -
Acute Bilateral Endophthalmitis Following Bilateral Intravitreal Bevacizumab (Avastin) Injection
por: Tabatabaii, Ali, et al.
Publicado: (2013) -
Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2014) -
Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008) -
Impact of Intravitreal Injection of Bevacizumab (Avastin) on Rabbit's Choroid and Retina
por: Karawya, Sherif, et al.
Publicado: (2008)